S Squared Technology’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.8M | Sell |
77,545
-8,670
| -10% | -$2.59M | 8.94% | 2 |
|
|
2026
Q1 | $22.3M | Sell |
86,215
-10,000
| -10% | -$2.66M | 8.43% | 2 |
|
|
2025
Q4 | $23.7M | Sell |
96,215
-13,000
| -12% | -$2.74M | 9.19% | 2 |
|
|
2025
Q3 | $19.3M | Hold |
109,215
| – | – | 7.33% | 2 |
|
|
2025
Q2 | $15M | Buy |
109,215
+12,000
| +12% | +$1.76M | 6.33% | 4 |
|
|
2025
Q1 | $17.5M | Buy |
97,215
+2,000
| +2% | +$336K | 8.97% | 1 |
|
|
2024
Q4 | $14.9M | Buy |
95,215
+20,000
| +27% | +$3.55M | 6.2% | 3 |
|
|
2024
Q3 | $13.7M | Sell |
75,215
-10,000
| -12% | -$1.93M | 5.84% | 4 |
|
|
2024
Q2 | $15.6M | Sell |
85,215
-5,000
| -6% | -$839K | 6.91% | 3 |
|
|
2024
Q1 | $16.1M | Sell |
90,215
-20,000
| -18% | -$2.78M | 7.37% | 2 |
|
|
2023
Q4 | $13.7M | Buy |
110,215
+2,000
| +2% | +$222K | 6.64% | 4 |
|
|
2023
Q3 | $12.6M | Hold |
108,215
| – | – | 6.77% | 3 |
|
|
2023
Q2 | $12.7M | Hold |
108,215
| – | – | 6.29% | 3 |
|
|
2023
Q1 | $8.66M | Hold |
108,215
| – | – | 5.14% | 7 |
|
|
2022
Q4 | $8.57M | Hold |
108,215
| – | – | 5.8% | 5 |
|
|
2022
Q3 | $7.54M | Hold |
108,215
| – | – | 5.52% | 7 |
|
|
2022
Q2 | $7.11M | Hold |
108,215
| – | – | 4.92% | 8 |
|
|
2022
Q1 | $7.2M | Buy |
108,215
+13,000
| +14% | +$811K | 3.59% | 12 |
|
|
2021
Q4 | $6.66M | Buy |
95,215
+10,000
| +12% | +$582K | 2.98% | 14 |
|
|
2021
Q3 | $4.45M | Hold |
85,215
| – | – | 2.02% | 20 |
|
|
2021
Q2 | $5.79M | Hold |
85,215
| – | – | 2.62% | 16 |
|
|
2021
Q1 | $6.57M | Hold |
85,215
| – | – | 3.1% | 12 |
|
|
2020
Q4 | $5.11M | Buy |
85,215
+5,000
| +6% | +$250K | 2.93% | 14 |
|
|
2020
Q3 | $3.45M | Buy |
80,215
+10,000
| +14% | +$434K | 2.57% | 15 |
|
|
2020
Q2 | $2.91M | Buy |
70,215
+10,000
| +17% | +$481K | 2.28% | 19 |
|
|
2020
Q1 | $2.6M | Hold |
60,215
| – | – | 2.53% | 15 |
|
|
2019
Q4 | $3.33M | Sell |
60,215
-7,318
| -11% | -$359K | 2.74% | 14 |
|
|
2019
Q3 | $2.35M | Hold |
67,533
| – | – | 2.07% | 23 |
|
|
2019
Q2 | $2.72M | Sell |
67,533
-1,367
| -2% | -$44.7K | 2.03% | 24 |
|
|
2019
Q1 | $2.27M | Sell |
68,900
-5,000
| -7% | -$118K | 1.75% | 26 |
|
|
2018
Q4 | $1.54M | Buy |
73,900
+20,000
| +37% | +$419K | 1.35% | 33 |
|
|
2018
Q3 | $948K | Buy |
+53,900
| New | +$904K | 0.74% | 37 |
|
Other funds holding KRYS
ACA
SCM
S Squared Technology's KRYS Position: Q2 2026 in Review
S Squared Technology reduced its Krystal Biotech (KRYS) stake by 10% in Q2 2026, selling an estimated $2.59M and leaving 77,545 shares worth $28.8M. The position accounts for 8.94% of the portfolio, ranked #2.
S Squared Technology first reported a position in KRYS in Q3 2018 and has held it in 32 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- S Squared Technology held 77,545 shares of Krystal Biotech worth $28.8M as of Q2 2026.
- S Squared Technology sold 8,670 Krystal Biotech shares in Q2 2026, an estimated $2.59M.
- Krystal Biotech made up 8.94% of S Squared Technology's portfolio in Q2 2026, its #2 holding.
- S Squared Technology first reported a position in Krystal Biotech in Q3 2018 and has held it in 32 quarters since.
- 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on S Squared Technology's 13F filing for Q2 2026, filed 14 Aug 2026.